Ricerca avanzata

Home > Riviste > Panminerva Medica > Fascicoli precedenti > Panminerva Medica 2014 Dicembre;56(4) > Panminerva Medica 2014 Dicembre;56(4):273-83

FASCICOLI E ARTICOLI   I PIÙ LETTI   eTOC

ULTIMO FASCICOLOPANMINERVA MEDICA

Rivista di Medicina Interna

Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,6

Periodicità: Trimestrale

ISSN 0031-0808

Online ISSN 1827-1898

 

Panminerva Medica 2014 Dicembre;56(4):273-83

MENOPAUSE IN 2014 

Osteoporosis therapies in 2014

Litwic A. 1, Cooper C. 1, 2, Dennison E. 1

1 MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton General Hospital, Southampton, UK;
2 IHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK

Osteoporosis is a systemic disorder characterized by low bone mass and microarchitectural deterioration of bone tissue with a consequent increase in bone fragility and susceptibility to fracture. It has a significant impact on public health through the increased morbidity, mortality, and economic costs associated with fractures. Despite the severe medical and socioeconomic consequences of fragility fractures, relatively few adults with fractures are evaluated and/or treated for osteoporosis. In this review, we summarize the existing treatment options and promising new therapies for the prevention and treatment of osteoporosis.

lingua: Inglese


FULL TEXT  ESTRATTI

inizio pagina